Abstract
In general, the regulatory basics for cosmetics are different in different countries. Even the classification rules defining what a cosmetic is differ between countries. A product that is classified as a cosmetic in one country may be classified as a drug in another country. This has implications for the testing of cosmetics. Depending on which country the testing is performed and/or the test product is (to be) marketed, different specific testing may be required, desirable and/or allowed. The following chapter gives a brief introduction on the regulatory aspects of clinical testing of cosmetics. However, this chapter serves for informational purposes only and does not provide legal advice.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McEwen, G.N., Murphy, E.G.: Cosmetic claim substantiation in the United States: legal considerations. In: Elsner, P., Merk, H.F., Maibach, H.I. (eds.) Cosmetics: Controlled Efficacy Studies and Regulation. Springer, Berlin (1999)
RPA Ltd. for European Commission Directorate General Enterprise: Comparative Study on Cosmetics Legislation in the EU and Other Principal Markets with Special Attention to so-called Borderline Products. Final Report – August 2004
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wunderlich, O. (2011). Regulatory Aspects. In: Fluhr, J.W. (eds) Practical Aspects of Cosmetic Testing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-05067-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-05067-1_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05066-4
Online ISBN: 978-3-642-05067-1
eBook Packages: MedicineMedicine (R0)